PT4:02 Landmark long-term remission achieved with ICG318, a BCMA-CD19 armored compound CAR T-cell therapy, in refractory systemic lupus erythematosus/lupus nephritis with follow-up approaching 6 years

Ming Hong(Zhongshan People's Hospital), Mingxia Wang(Zhongshan People's Hospital), Ronghao Zeng(Zhongshan People's Hospital), Ling Ding(Zhongshan People's Hospital), Shanzhi He(Zhongshan People's Hospital), Ting Lan(Zhongshan People's Hospital), Vincent Destefano(Zhongshan People's Hospital), Masayuki Wada(Zhongshan People's Hospital), Kevin G. Pinz(Zhongshan People's Hospital), Jennifer Chow(Zhongshan People's Hospital), Byeong Hyeok Choi(Zhongshan People's Hospital), Nabil Hagag(Zhongshan People's Hospital), M Wang(Zhongshan People's Hospital), Yu Ma(Zhongshan People's Hospital), Jing Luo, Yingwen Liang(Zhongshan People's Hospital), Shihao Ding(Zhongshan People's Hospital), Ziji Lu(Zhongshan People's Hospital), Qinglian Jiang(Zhongshan People's Hospital), Wenli Zhang(Peking University Shenzhen Hospital), Yupo Ma(Zhongshan People's Hospital), Weijia Wang(Zhongshan People's Hospital)
Unknown
March 1, 2026
10.1136/lupus-2026-el.49
Cited by 0Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis